Skin cancer is the most common form of human cancer. The annual rates of all forms of skin cancer are increasing each year, representing a growing public health problem. The two most common form of skin cancer are basal cell and squamous cell carcinoma, well known as nonmelanoma skin cancer. Treatment of nonmelanoma skin cancer depends on the type and location of the skin cancer as well as the age and general health of the patient. Surgical excision is the most common metod in the treatment of basal and squamous cell carcinoma. One of disadvantages of simple surgical excision is incomplete margin control. The aim of this prospective study was to assess the influence of the size of the tumor and intraoperative surgical margin on the rate of complete excisions of skin cancer. A total of 64 basal cell and squamous cell carcinomas were excised and analyzed. Data pertaining to patient age, sex, lesion size and margin of excision were collected prospectively. After excision, all tumors specimens were histopathology confirmed completeness/ incompleteness of tumor excision. Tumor size ranged from 5mm to 36mm. Surgical margins were used in the range of 5-12mm. Skvamocelularni carcinomas were incompletely removed in 4.2%, and basal cell carcinomas in 10% of cases within the histopathological groups. Basal cell carcinomas: surgical margin of 5 mm radically removed 83.3% (up to 1cm); 8mm margin- 86.7% (1-2cm): and 10mm 100% (over 3cm). Squamous cell carcinomas: 10mm surgical margin removed 100% tumors up to 3cm.
Dieu T, Macleod AM. Incomplete excision of basal cell carcinomas: a retrospective audit. ANZ Journal of Surgery. 72(3):219–21.
2.
Marks R. The epidemiology of non-melanoma skin cancer: who, why, and what can be done about it. Journal of Dermatology. 22(11):853–7.
3.
Tiftikcioglu YO, Karaaslan O, Aksoy HM. Basal cell carcinoma in Turkey. Journal of Dermatology. 2:91–5.
4.
Conway C, Huang MD, Boyce SM. Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Seminars in Cutaneous Medicine and Surgery. 23:167–73.
5.
Tan PY, Ek E, Su S, Giorlando F, Dieu T. Incomplete excision of squamous cell carcinoma of the skin: a prospective observational study. Plastic and Reconstructive Surgery. 120(4):910–6.
6.
Talbot S, Hitchcock B. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty. Journal of the New Zealand Medical Association. 117:1192–6.
7.
Griffiths RW. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by reexcision. British Journal of Plastic Surgery. 52:24–8.
8.
Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Archives of Dermatology. 123:387–94.
9.
Pang PC. Nonmelanoma skin cancer. Medical Bulletin. 13(7):9–11.
10.
Alam M, Ratner D. Cutaneous squamous cell carcinoma. New England Journal of Medicine. 344:975–83.
11.
Walker P, Hill D. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australasian Journal of Dermatology. 47(1):1–12.
12.
Kumar P, Orton CI, McWilliam LJ, Watson S. Incidence of incomplete excision in surgically treated basal cell carcinomas: a retrospective clinical audit. British Journal of Plastic Surgery. 53:563–6.
13.
Hallock GG, Lutz DA. A prospective study of the accuracy of the surgeon’s diagnosis and significance of positive margins in non-melanoma skin cancer. Plastic and Reconstructive Surgery. 107:942–7.
14.
Mackie RM. Epidermal skin tumors. In: Rook/Wilkinson/Ebling Textbook of Dermatology. p. 1679–84.
15.
Hussain M, Earley MJ. The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. Irish Medical Journal. 96(1):18–20.
16.
Wettstein R, Erba P, Farhadi J, Kalbermatten DF, Arnold A, Haug M, et al. Incomplete excision of basal cell carcinoma in the subunits of the nose. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 42(2):92–5.
17.
Griffiths RW, Suvarna SK, Stone J. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumors. Wider still and deeper? Journal of Plastic, Reconstructive & Aesthetic Surgery. 60(1):41–7.
18.
Pua VS, Huilgol S, Hill D. Evaluation of the treatment of non-melanoma skin cancers by surgical excision. Australasian Journal of Dermatology. 50(3):171–5.
19.
Chiller K, Passaro D, McCalmont T, Vin-Christian K. Efficacy of curettage before excision in clearing margins of nonmelanoma skin cancer. Archives of Dermatology. 136:1327–32.
20.
Abide J, Nahai F, Bennett R. The meaning of surgical margins. Plastic and Reconstructive Surgery. 73(3):492–6.
21.
Shah SA. An assessment of incomplete facial basal cell carcinoma excision. Journal of the College of Physicians and Surgeons Pakistan. 15(3):149–51.
22.
Su SY, Giorlando F, Ek EW, Dieu T. Incomplete excision of basal cell carcinoma: a prospective trial. Plastic and Reconstructive Surgery. 120(5):1240–8.
23.
Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Journal of the American Academy of Dermatology. 26:976–90.
24.
Ang P, Tan AW, Goh CL. Comparison of completely versus incompletely excised cutaneous squamous cell carcinomas. Annals of the Academy of Medicine Singapore. 33:68–70.
25.
Kimyai AA, Alam M, Goldberg LH, Peterson S, S J, M.H. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas. Journal of the American Academy of Dermatology. 53(3):464–8.
26.
Joshua E, David KE. Surgical margins in the treatment of nonmelanoma skin cancer and Mohs micrographic surgery. Current Surgery. 62(5):20–5.
27.
Pruthi DK, Guilfoyle R, Nugent Z, Wiseman MC, Demers AA. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005. Journal of the American Academy of Dermatology. 61(1):44–50.
28.
Geller AC, Annas GD. Epidemiology of melanoma and nonmelanoma skin cancer. Seminars in Oncology Nursing. 19:2–11.
29.
Rodriguez VT, Vázquez L, Perez ON. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. Journal of the American Academy of Dermatology. 56(1):91–5.
30.
McGuire JF, Ge NN, Dyson S. Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior. American Journal of Otolaryngology. 30(2):121–33.
31.
Ge NN, McGuire JF, Dyson S, Chark D. Nonmelanoma skin cancer of the head and neck II: surgical treatment and reconstruction. American Journal of Otolaryngology. 30(3):181–92.
32.
Zuazaga JG, Olbricht SM. Cutaneous squamous cell carcinoma. Advances in Dermatology. 24:33–57.
33.
Ricotti C, Bouzari N, Agadi A, Cockerell CJ. Malignant skin neoplasms. Vol. 93.
34.
Feldman S, Pearce DJ, Williford PM. Surgical decision making for basal-cell carcinoma of the face. The Lancet Oncology. 9(12):1119–20.
35.
Gage AA, Baust JG. Cryosurgery for tumors. Journal of the American College of Surgeons. 205(2):342–56.
36.
Madan CA, West JV, Murphy J, Lear T. Sequential treatment of giant basal cell carcinomas. Journal of Plastic, Reconstructive & Aesthetic Surgery. 62(10):368–72.
37.
Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. The Lancet Oncology. 9(12):1149–56.
38.
Hexsel CL, Eide M, Krajenta R, Johnson CC, Hamzavi I, Lim HW. Incidence of nonmelanoma skin cancer in a cohort of 479 vitiligo patients. Journal of the American Academy of Dermatology. 58(2):9–10.
39.
Breuninger H. Histologic control of excised tissue edges in the operative treatment of basal-cell carcinomas. Journal of Dermatologic Surgery and Oncology. 10(9):724–8.
40.
Breuninger H, Shaumburg-Lever G. Control of excisional margins by conventional histopathological techniques in the treatment of skin tumours. An alternative to Mohs technique. Journal of Pathology. 154:167–71.
41.
Ridky TW. Nonmelanoma skin cancer. Journal of the American Academy of Dermatology. 57(3):484–501.
42.
Zhang B, Wang N, He W. Clinicopathologic analysis of 60 cases of basal cell carcinoma. Chinese Medical Science Journal. 8:121.
43.
Cho S, Kim MH, Whang KK. Clinical and histopathological characteristics of basal cell carcinoma in Korean patients. Journal of Dermatology. 26:494–501.
44.
Betti R, Inselvini E, Carducci M. Age and site prevalence of histologic subtypes of basal cell carcinomas. International Journal of Dermatology. 34:174–6.
45.
Rowe D, Gallagher R, Warshawski D, Carruthers A. Females vastly outnumber males in basal cell carcinoma of the upper lip. A peculiar subset of high young females is described. Journal of Dermatologic Surgery and Oncology. 20(11):754–6.
46.
Bariani RL, Nahas FX, Barbosal MV. Basal cell carcinoma: an updated epidemiological and therapeutically profile of an urban population. Acta Cirúrgica Brasileira. 21(2):123–6.
47.
Czarnecki D, Collins N, Meehan C. Basal cell carcinoma in temperate and tropical Australia. International Journal of Cancer. 50:874–5.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
